Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$937,737
+$576,150 QoQ
Shares Held
7,650
+2.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#182
of 341 holders
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRED ALGER MANAGEMENT, LLC holds $748,337,711 across 53 Biotechnology names. PTGX ranks #39 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,301,919 | $269,139,417 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,302,493 | $126,967,017 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
259,468 | $48,593,167 | |
| 4 | ASND |
Ascendis Pharma A/S
|
171,447 | $45,728,343 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
1,072,830 | $41,518,521 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,081,421 | $38,271,489 | |
| 7 | FBRX |
Forte Biosciences, Inc.
|
1,439,697 | $30,593,561 | |
| 8 | ERAS |
Erasca, Inc.
|
1,308,455 | $23,970,895 |
All Filings in PTGX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $937,737 | 7,650 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $361,587 | 7,477 | Shares | Sole | 2025-05-16 | |
| 2023-06-30 | $599,878 | 21,719 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $266,915 | 11,605 | Shares | Sole | 2023-05-16 | |
| No filing history on record for this holder in this stock. | ||||||